The Indian Supreme Court’s Novartis Decision – A View from India

• By: Dr. Uday Shetty, founder and Executive Director of Drug Regulations
• Date: April 18, 2013
• Source: http://www.drugregulations.org/2013/04/the-gleevec-chicanery.html

In this article, Dr Uday Shetty, founder and Executive Director of Drug Regulations, a non-profit organization, provides insight into the recent Indian Supreme Court's decision on the Novartis cancer drug Gleevac and explains the reasoning behind the court's ruling on not granting a patent for the product.